// App-Quantinova.ai

3329 : Increasing the efficacy of cancer stem cell-based vaccine in the PD-L1/PD-1 blockade

Researchers

Presenter

  • Yangyang Hu

Principal Investigators

  • Yang Xia

  • Xin Chen

  • Li Zhou

  • Yangyi Bao

  • Shiang Huang

  • Xiubao Ren

  • Elaine Hurt

  • Robert E. Hollingsworth

  • Alfred E. Chang

  • Max S. Wicha

  • Qiao Li

Medical Centers

  • University of Michigan Comprehensive Cancer Center, Ann Arbor, MI

  • The Third Affiliated Hospital of Beijing Medical University, Beijing, China

  • Center for Stem Cell Research and Application, Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, China

  • Department of Biotherapy, Tianjin University Cancer Institute and Hospital, China

  • MedImmune, Gaithersburg, MD

Locations

  • United States

  • China

Companies

  • MedImmune Inc. (Astr

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Squamous cell carcinoma

  • Mammary carcinoma

  • Melanoma

  • Solid malignancies

Biomarkers

  • Immunoglobulin G

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved